abnormal bone structure_Esrra<tm1Vgi>/Esrra<tm1Vgi>

http://metadb.riken.jp/0003795I129S1Sv129X1SvJEsrratm1VgiEsrratm1VgiEsrratm1Vgi

abnormal bone structure_Esrra<tm1Vgi>/Esrra<tm1Vgi>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• estrogen related receptor, alpha
  http://metadb.riken.jp/db/mgi_rdf/MGI:1346831

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Esrra<tm1Vgi>/Esrra<tm1Vgi>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Esrra<tm1Vgi>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal bone structure
  http://purl.obolibrary.org/obo/MP_0003795

文献

http://purl.org/net/cito/citesAsAuthority

• Wei. Wei, et.al., PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss., Cell metabolism, 2010, 11
  http://rdf.ncbi.nlm.nih.gov/pubmed/20519122